Visiongain Report Claims There is Huge Potential Within the $39bn Dermatological Drugs Market
- Friday, November 29, 2019, 5:13
- PR Newswire
- Add a comment
LONDON, Nov. 29, 2019 /PRNewswire/ — The revenue of the dermatological drugs market in 2018 is estimated at $31bn and is expected to grow at a CAGR of 3.7% in the first half of the forecast period. Psoriasis drugs segment accounted for the largest share of the market in 2018, this…
About the Author
admin has written 20652 stories on this site.